Published in Neuropsychopharmacology on February 29, 2012
Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med (2014) 3.17
Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev (2012) 1.67
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol. Drug Alcohol Depend (2013) 1.20
Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev (2014) 1.03
ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework. Front Psychiatry (2014) 1.02
Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci (2016) 1.01
Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment. Front Psychiatry (2015) 0.99
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials (2014) 0.92
Novel Pharmacologic Approaches to Treating Cannabis Use Disorder. Curr Addict Rep (2014) 0.87
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend (2015) 0.86
Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy (2016) 0.83
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract (2016) 0.83
Youth marijuana use: state of the science for the practicing clinician. Curr Opin Pediatr (2014) 0.82
Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology (Berl) (2014) 0.81
γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers. Drug Alcohol Depend (2013) 0.80
Cannabinoid abuse and addiction: Clinical and preclinical findings. Clin Pharmacol Ther (2015) 0.80
Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review. Subst Abuse Rehabil (2016) 0.80
α2δ-1 signaling in nucleus accumbens is necessary for cocaine-induced relapse. J Neurosci (2014) 0.79
The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology (2017) 0.79
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure. Neuropsychopharmacology (2017) 0.78
Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats. Psychopharmacology (Berl) (2015) 0.78
Advances in Medications and Tailoring Treatment for Alcohol Use Disorder. Alcohol Res (2015) 0.78
Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol. Behav Pharmacol (2016) 0.77
WHY NOT POT?: A Review of the Brain-based Risks of Cannabis. Innov Clin Neurosci (2016) 0.77
Open-label pilot study of quetiapine treatment for cannabis dependence. Am J Drug Alcohol Abuse (2014) 0.77
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study. J Drug Issues (2016) 0.77
New Developments in Understanding and Treating Adolescent Marijuana Dependence. Adolesc Psychiatry (Hilversum) (2013) 0.77
Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study. Addict Biol (2016) 0.76
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Drug Alcohol Depend (2016) 0.76
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug Alcohol Depend (2014) 0.76
The cannabis withdrawal syndrome: current insights. Subst Abuse Rehabil (2017) 0.76
Evidence-based Treatment Options in Cannabis Dependency. Dtsch Arztebl Int (2016) 0.75
The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders. Child Adolesc Psychiatr Clin N Am (2016) 0.75
Screening Medications for the Treatment of Cannabis Use Disorder. Int Rev Neurobiol (2016) 0.75
Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. Am J Drug Alcohol Abuse (2016) 0.75
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review. CNS Drugs (2016) 0.75
Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions. Curr Addict Rep (2016) 0.75
Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study. Am J Addict (2017) 0.75
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
Random-effects models for longitudinal data. Biometrics (1982) 54.17
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess (1996) 16.96
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 10.34
The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol (2000) 7.71
Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry (2004) 6.05
Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17
Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci (2005) 4.36
Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol (2000) 4.34
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
The time course and significance of cannabis withdrawal. J Abnorm Psychol (2003) 2.70
Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction (1999) 2.51
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50
SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull (1986) 2.46
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med (2011) 2.06
Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev (2010) 2.00
Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol (1998) 1.99
Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict (2006) 1.94
Cellular and behavioral interactions of gabapentin with alcohol dependence. J Neurosci (2008) 1.91
The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol (2005) 1.88
Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol (2010) 1.81
Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat (2008) 1.73
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2011) 1.62
Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval Health Prof (2009) 1.56
Treatment of cannabis use disorders: a review of the literature. Am J Addict (2007) 1.48
Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict (2004) 1.46
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35
Gabapentin treatment for insomnia associated with alcohol dependence. Am J Psychiatry (2000) 1.21
Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol (2008) 1.17
Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol (2009) 1.16
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend (2009) 1.10
Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology (2005) 1.09
Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry (1998) 0.99
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict (2010) 0.95
Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study. J Anal Toxicol (1999) 0.92
Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med (2010) 0.92
A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia (1999) 0.92
Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol (2010) 0.90
Neurochemical basis of cannabis addiction. Neuroscience (2011) 0.88
An innovative, sensorless, pulsatile, continuous-flow total artificial heart: device design and initial in vitro study. J Heart Lung Transplant (2009) 2.42
Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol Methods (2005) 2.16
In vivo acute performance of the Cleveland Clinic self-regulating, continuous-flow total artificial heart. J Heart Lung Transplant (2009) 1.64
Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. J Proteome Res (2008) 1.59
Understanding college drinking: assessing dose response from survey self-reports. J Stud Alcohol (2003) 1.39
Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer. Cancer Res (2008) 1.24
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine. J Clin Oncol (2004) 1.19
Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol (2008) 1.17
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera. Cancer Prev Res (Phila) (2012) 1.15
Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase. Cancer Res (2005) 1.14
Factors affecting the stability of social networks during early recovery in ex-offenders. Am J Drug Alcohol Abuse (2014) 1.13
Evaluation of immobility time for sleep latency in actigraphy. Sleep Med (2008) 1.13
Alcohol consumption and problems: the relevance of drinking patterns. Alcohol Clin Exp Res (2004) 1.12
Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Psychopharmacology (Berl) (2008) 1.11
Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients. J Clin Immunol (2004) 1.07
Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J Clin Endocrinol Metab (2009) 1.06
Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals. Psychopharmacology (Berl) (2011) 1.05
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming. Clin Cancer Res (2007) 1.01
Dynamic social networks in recovery homes. Am J Community Psychol (2014) 1.00
Fundamental Principles of Network Formation among Preschool Children. Soc Networks (2010) 0.98
Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J Clin Invest (2015) 0.95
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers. Clin Immunol (2007) 0.93
Drinking to extremes: theoretical and empiricalanalyses of peak drinking levels among college students. J Stud Alcohol (2003) 0.92
Sleep duration and breast cancer phenotype. J Cancer Epidemiol (2013) 0.89
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells. J Immunother (2003) 0.89
Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor. Colloids Surf B Biointerfaces (2008) 0.89
Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer. Expert Opin Ther Targets (2007) 0.86
Acamprosate in the treatment of alcohol dependence: clinical and economic considerations. Expert Rev Neurother (2007) 0.82
Psychosocial correlates of physical and sedentary activities of early adolescent youth. Health Educ Behav (2013) 0.81
Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity. Breast Cancer Res Treat (2008) 0.81
Ethnic differences in driving after drinking and riding with drinking drivers among adolescents. Alcohol Clin Exp Res (2003) 0.81
In vivo biocompatibility evaluation of a new resilient, hard-carbon, thin-film coating for ventricular assist devices. Artif Organs (2010) 0.80
Concurrent and predictive associations between early adolescent perceptions of peer affiliates and mood states collected in real time via ecological momentary assessment methodology. Psychol Assess (2012) 0.78
Mitral annular remodeling to treat functional mitral regurgitation: a pilot acute study in a canine model. Heart Surg Forum (2010) 0.76
In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells. ASAIO J (2011) 0.75
The Relationship of Sense of Community and Trust to Hope. J Community Psychol (2016) 0.75
Acute feasibility study of a novel device for the treatment of mitral regurgitation in a normal canine model. Innovations (Phila) (2010) 0.75
A Longitudinal Study Predicting Adolescent Tobacco, Alcohol, and Cannabis Use by Behavioral Characteristics of Close Friends. Psychol Addict Behav (2017) 0.75
Direct endoscopy-guided mitral valve repair in the beating heart: an acute animal study. Innovations (Phila) (2011) 0.75